Top-News
Biotechnologie USA

Amicus Therapeutics Inc News

Aktie
WKN:  A0MSMZ ISIN:  US03152W1099 US-Symbol:  FOLD
8,90 €
-0,05 €
-0,56%
16.05.24 11:30:28
Handeln Depot/Watchlist
Aktienanzahl *
295,38 Mio.
Marktkapitalisierung *
2,65 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 19.04.2024

Amicus Therapeutics Inc News

01.10.23 - PR Newswire
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease PR Newswire
14.11.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD PR Newswire
29.09.21 - PR Newswire
Thinking about buying stock in Applied UV, Fortress Biotech, Geovax Labs, Amicus Therapeutics, or Lucid Group?
Thinking about buying stock in Applied UV, Fortress Biotech, Geovax Labs, Amicus Therapeutics, or Lucid Group? PR Newswire
20.08.21 - The Motley Fool
Ist jetzt die Zeit, um 5 der schlechtesten Performer der Nasdaq von 2021 zu kaufen?
Wenn es dir wie vielen anderen Anlegern geht, beginnt deine Suche nach Schnäppchenaktien mit Titeln, die stark abverkauft wurden. Und das ist auch gut so. Der Markt ist in der ...
14.04.21 - PR Newswire
Thinking about buying stock in Grupo Televisa, Phunware, Immunitybio, Flexion Therapeutics, or Amicus Therapeutics?
Thinking about buying stock in Grupo Televisa, Phunware, Immunitybio, Flexion Therapeutics, or Amicus Therapeutics? PR Newswire
06.02.17 - PR Newswire
The Biotech Market Grows as Demand for New Therapeutics Increases
The Biotech Market Grows as Demand for New Therapeutics Increases PR Newswire
01.12.16 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD PR Newswire
29.11.16 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amicus Therapeutics, Inc. (FOLD)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amicus Therapeutics, Inc. (FOLD) PR Newswire
03.03.16 - PR Newswire
Covered Call Alerts For Bank of America, Twitter, Inovio Pharmaceuticals, Marathon Oil Corporation and Amicus Therapeutics Released By InvestorsObserver
Covered Call Alerts For Bank of America, Twitter, Inovio Pharmaceuticals, Marathon Oil Corporation and Amicus Therapeutics Released By InvestorsObserver PR Newswire
01.12.15 - PR Newswire
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Amicus Therapeutics, Inc. and Lead Plaintiff Deadline December 7, 2015
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Amicus Therapeutics, Inc. and Lead Plaintiff Deadline December 7, 2015 PR ...
11.11.15 - PR Newswire
Wolf Popper LLP Updates Investigation and Reminds Shareholders of Amicus Therapeutics, Inc. of Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
Wolf Popper LLP Updates Investigation and Reminds Shareholders of Amicus Therapeutics, Inc. of Class Action Lawsuit and Upcoming Lead Plaintiff Deadline PR Newswire
02.11.15 - PR Newswire
Law Offices of Marc S. Henzel Commences Investigations of Fifth Street Finance Corp., Amicus Therapeutics, Inc., 6D Global Technologies, Inc., BofI Holdings, Inc., Zafgen, Inc., and Valeant Pharmaceut
Law Offices of Marc S. Henzel Commences Investigations of Fifth Street Finance Corp., Amicus Therapeutics, Inc., 6D Global Technologies, Inc., BofI Holdings, Inc., Zafgen, Inc., and ...
30.10.15 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2015 - FOLD
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amicus Therapeutics, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of December ...
16.10.15 - PR Newswire
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Amicus Therapeutics, Inc.
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Amicus Therapeutics, Inc. PR Newswire
13.10.15 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Amicus Therapeutics, Inc. and Certain Officers - FOLD
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Amicus Therapeutics, Inc. and Certain Officers - FOLD PR Newswire
09.10.15 - PR Newswire
Harwood Feffer LLP Announces Investigation of Amicus Therapeutics, Inc.
Harwood Feffer LLP Announces Investigation of Amicus Therapeutics, Inc. PR Newswire
08.10.15 - PR Newswire
Amicus Therapeutics, Inc. Sued for Securities Fraud In An Expanded Class Period
Amicus Therapeutics, Inc. Sued for Securities Fraud In An Expanded Class Period PR Newswire
07.10.15 - PR Newswire
Amicus Therapeutics, Inc. Sued for Securities Fraud After Revealing Its NDA Will Not Be Filed This Year
Amicus Therapeutics, Inc. Sued for Securities Fraud After Revealing Its NDA Will Not Be Filed This Year PR Newswire
02.10.15 - PR Newswire
Block & Leviton LLP Investigates Amicus Therapeutics After Announcement That It Will Not File A New Drug Application This Year As Originally Announced
Block & Leviton LLP Investigates Amicus Therapeutics After Announcement That It Will Not File A New Drug Application This Year As Originally Announced PR Newswire
02.10.15 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amicus Therapeutics, Inc.
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amicus Therapeutics, Inc. PR Newswire

Newssuche

Videos

newspaper
17.05.24 +7,67%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »